Moreover, STAT3 downstream of EGFR signaling pathway could promote the transcription of UTX, suggesting an “EGFR-STAT3-UTX” axis that participates in the progression of NSCLC, and can at least partly explain the higher levels of UTX in NSCLC tumor tissues comparing to normal samples. Here, KDM6A is linked to neoplasm.